UIM1:F:F-UBS ETF SICAV - Euro Stoxx 50 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 50.01

Change

-0.46 (-0.91)%

Market Cap

USD 0.49B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.09%)

USD 115.53B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.09%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.94B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.94B

ETFs Containing UIM1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.90% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.90% 50% F 53% F
Trailing 12 Months  
Capital Gain 10.49% 43% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.49% 39% F 47% F
Trailing 5 Years  
Capital Gain 46.98% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.98% 65% D 54% F
Average Annual (5 Year Horizon)  
Capital Gain 10.35% N/A N/A 70% C-
Dividend Return 10.35% N/A N/A 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.90% N/A N/A 74% C
Risk Adjusted Return 65.07% N/A N/A 80% B-
Market Capitalization 0.49B 58% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike